Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
Each RSU represents a contingent right to receive one share of the issuer's common stock at settlement.
Pursuant to the terms of the RSU, the total underlying shares ves
t when certain performance criteria relating to the issuer are met.
The RSUs expire 30 days from the date they vest.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever OncoGenex Pharmaceuticals Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
OncoGenex Pharmaceuticals Inc. just filed a General Statement of acquisition of beneficial ownership - Nov. 7, 2014
Oncogenex Pharmaceuticals, Inc. Reports Financial Results For Third Quarter 2014 - Oct. 30, 2014
OncoGenex Pharmaceuticals Inc. Just Filed Its Quarterly Report: 8. SUBSEQUENT EV... - Oct. 30, 2014